{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:34:25Z","timestamp":1777448065019,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jdermsci.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T16:05:41Z","timestamp":1473869141000},"page":"351-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD"],"prefix":"10.1016","volume":"84","author":[{"given":"Graham","family":"Elliott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vanwersch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Soeberdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Metze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Lotts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Abels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.09.008_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/00015555-1353","article-title":"Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0010","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.jid.5700942","article-title":"Possible roles of epidermal opioid systems in pruritus of atopic dermatitis","volume":"127","author":"Tominaga","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1517\/14656566.2012.693164","article-title":"Nalfurafine hydrochloride for the treatment of pruritus","volume":"13","author":"Inui","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0020","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstrom","year":"2005","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0025","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrol. Dialysis Transpl."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","article-title":"Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients","volume":"36","author":"Kumagai","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1254\/jphs.10050FP","article-title":"Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice","volume":"113","author":"Tsukumo","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1056-8719(01)00111-3","article-title":"An automated method for registering and quantifying scratching activity in mice: use for drug evaluation","volume":"44","author":"Elliott","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1358\/dot.2009.45.5.1377595","article-title":"Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients","volume":"45","author":"Nakao","year":"2009","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.jdermsci.2016.09.008_bib0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jdermsci.2010.03.007","article-title":"Scratching behavior does not necessarily correlate with epidermal nerve fiber sprouting or inflammatory cell infiltration","volume":"58","author":"Kido","year":"2010","journal-title":"J. Dermatol. Sci."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116307708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116307708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T08:51:48Z","timestamp":1536396708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116307708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0923181116307708"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.09.008","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}